MARKET

ADAG

ADAG

Adagene Inc.
NASDAQ
1.510
+0.060
+4.14%
Closed 16:00 03/29 EDT
OPEN
1.450
PREV CLOSE
1.450
HIGH
1.590
LOW
1.411
VOLUME
7.29K
TURNOVER
8.55K
52 WEEK HIGH
4.433
52 WEEK LOW
0.9000
MARKET CAP
65.57M
P/E (TTM)
-0.7878
1D
5D
1M
3M
1Y
5Y
HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target
Benzinga · 19h ago
H.C. Wainwright Reaffirms Their Buy Rating on Adagene (ADAG)
TipRanks · 19h ago
BRIEF-Adagene Reports Full Year 2022 Financial Results And Provides Corporate Update
Reuters · 1d ago
Adagene ADR GAAP EPS of -$1.48 beats by $0.04, revenue of $9.29M beats by $0.45M
Seeking Alpha · 1d ago
Adagene FY22 EPS $(1.48) Beats $(1.58) Estimate, Sales $9.29M Beat $8.87M Estimate
Benzinga · 1d ago
H.C. Wainwright Sticks to Its Buy Rating for Adagene (ADAG)
TipRanks · 03/21 10:15
Morgan Stanley Sticks to Its Buy Rating for Adagene (ADAG)
TipRanks · 01/24 16:26
Morgan Stanley Adjusts Price Target on Adagene to $5 From $7, Maintains Overweight Rating
Morgan Stanley Adjusts Price Target on Adagene to $5 From $7, Maintains Overweight Rating
MT Newswires · 01/24 09:04
More
About ADAG
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.

Webull offers kinds of Adagene Inc stock information, including NASDAQ:ADAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADAG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADAG stock methods without spending real money on the virtual paper trading platform.